Similarly, metastatic lesions had lower methylation levels of T-UCRs (Figure 3G–I) compared to adenocarcinomas, although only for Uc346 this difference was statistically significant (p = 0.038, Figure 3I). This evidence concerns the gene RFX4-AS1 and adenocarcinoma.